^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Lung Non-Small Cell Squamous Cancer |
| Drug: | Gilotrif (afatinib) (EGFR inhibitor, HER2 inhibitor, HER4 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
GILOTRIF is a kinase inhibitor indicated for:...Treatment of patients with metastatic, squamous NSCLC progressing after platinum-based chemotherapy
